Aim Toxoplasmosis following liver transplant with donor-recipient mismatch is rare, but is often lifethreatening. However, there are no data on the frequency of cyst carriage in the liver, nor consensual chemoprophylaxis guidelines. This study aimed at describing frequency and localisation of Toxoplasma cysts in the liver in a mouse model of chronic infection to predict the risk in liver transplantation. Methods Heart, brain and liver lobes of 21 mice chronically infected with Toxoplasma were collected for DNA extraction and amplification of Toxoplasma gondii rep529 sequence by real-time PCR.
The liver as an organ at risk for Toxoplasma transmission during transplantation: myth or reality?
AbsTrACT Aim Toxoplasmosis following liver transplant with donor-recipient mismatch is rare, but is often lifethreatening. However, there are no data on the frequency of cyst carriage in the liver, nor consensual chemoprophylaxis guidelines. This study aimed at describing frequency and localisation of Toxoplasma cysts in the liver in a mouse model of chronic infection to predict the risk in liver transplantation. Methods Heart, brain and liver lobes of 21 mice chronically infected with Toxoplasma were collected for DNA extraction and amplification of Toxoplasma gondii rep529 sequence by real-time PCR. results Parasite DNA was detected in the liver of 19/21 mice (90.5%), with no preferential anatomical localisation, but with higher parasite loads in the papillary process. Parasite loads in the liver were far lower than in brain and heart. The number of infected lobes was inversely correlated to the total liver weight, but was independent of the brain parasite load and of the parasite strain. Conclusions The liver is a frequent site of cyst carriage, confirming that transplantation of an organ from a seropositive donor to seronegative recipient is at high risk for acquired toxoplasmosis. Systematic serological screening prior to transplantation and chemoprophylaxis in patients at risk are fully justified.
InTrOduCTIOn
Toxoplasma gondii is a worldwide spread Apicomplexa, which can infect a large diversity of warmblooded animals. When infecting a new host, this intracellular parasite disseminates in the organism and then encysts in tissues, with a preferred localisation in brain, muscles, myocardium and retina. As Toxoplasma can virtually invade all types of nucleated cells, these cysts can be found virtually in all organs. Cysts are structures containing hundreds of bradyzoites, quiescent forms with a slower metabolism. They persist lifelong in their host and are resistant to all current therapies.
Toxoplasmosis is usually benign for immunocompetent people, as it is most often asymptomatic. However, there are two conditions where disease can be severe, that is, (i) when primary infection is acquired during pregnancy, T. gondii can be responsible for congenital toxoplasmosis and (ii) in case of immune cell deficiency, latent cysts may reactivate, in particular following HIV infection or transplantation. In immunocompromised patients, reactivation infection often results in cerebral toxoplasmosis or disseminated toxoplasmosis and leads to death in the absence of treatment. Toxoplasma can be transmitted through organ transplantation, in case of donor-recipient mismatch (Toxoplasma-seropositive donor/Toxoplasma-seronegative recipient). This way of infection concerns essentially cardiac transplants, as cysts burden is known to be high in this tissue.
1 Organ-transmitted infection or reactivation infection can be prevented by chemoprophylaxis with cotrimoxazole. Infection through other types of transplants is also possible, although more rarely reported in the literature. 2 Published cases of toxoplasmosis following liver transplantation are scarce. Indeed, 31 cases have been reported since 40 years and only about 10 were consecutive to a Toxoplasma mismatch.
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Therefore, prophylaxis is irregularly prescribed after liver transplantation. 12 Even if this way of infection is unfrequently described, it is often life-threatening. Nevertheless, no data are available regarding the frequency of cyst carriage in the liver in patients with past immunity, nor regarding the precise hepatic localisation.
This study approached these questions using a murine model in the aim to better characterise the Toxoplasma-associated risk in liver transplantation. In contrast to classical experimental models using standardised parasite inoculums of a given parasite strain, unlikely reflecting human contamination, we used mice diagnosed with Toxoplasma infection in the framework of in vivo diagnosis of congenital toxoplasmosis. This in vivo assay has been routinely used in France since about 30 years. A few laboratories still use it together with quantitative PCR assays, mainly for epidemiological studies, although its sensitivity to detect viable parasites in placenta samples may have added value for the neonatal diagnosis of congenital toxoplasmosis.
13

MeThOds
Mice and organs
Four to six Swiss female mice (Janvier LABS, Saint-Berthevin, France) were inoculated intraperitoneally with previously digested placenta, as part of our routine diagnosis and epidemiological survey of congenital toxoplasmosis, as previously described. 13 Five to 6 weeks later, a blood sample was taken from the submandibular vein and Toxoplasma serology was performed using the Toxoscreen assay (Biomérieux, Marcy L'Etoile, France) to screen infected animals. All seropositive mice were sacrificed. One brain was collected for each clinical sample to confirm the presence of cysts by microscopic examination and was sent to the National Reference Center (NRC) for genotyping. Our animal facility follows the European For this study purpose, liver and heart were collected together with brain for 21 seropositive mice. Liver was perfused with 5-8 mL of phosphate buffered saline (PBS) through the portal vein to flush all blood cells, then weighed and lobes were separated following the anatomical structure presented in figure 1. Lobes and heart specimens were weighed with a precision scale and crushed in 3.6 mL (left lateral lobe) or 1.8 mL (other lobes and hearts) of Tris-EDTA buffer (50 mM Tris and 50 mM EDTA) and the entire volume was extracted as described in the following step. The entire brains were crushed in 2 mL of Tris-EDTA but only 900 µL were extracted. Samples not processed immediately were frozen at −80°C before DNA extraction.
Phenol-chloroform dnA extraction
DNA extraction was performed after a proteinase K pretreatment consisting in overnight incubation with sodium dodecyl sulfate (SDS) (0.9%) and proteinase K (0.05 µM) at 56°C. After addition of phenol (V/V), samples were gently shaked during 10 min and centrifuged (10 min, 2500 g, room temperature). Supernatants were collected and a solution of phenol-chloroform-isoamyl alcohol (25/24/1) was added (V/V) to each sample before new gentle shaking and centrifugation. Supernatants were collected, added with chloroform-isoamyl alcohol (96/4) (V/V), shaked gently and centrifuged again. DNA present in aqueous phase was precipitated in 100% ethanol and sodium acetate 3 M, and DNA pellets were washed with 70% ethanol, then dried. Pellets were then dissolved in water in a final volume of 400 µL. Extracts were frozen at −80°C for later use.
Quantification of parasite loads by real-time PCr
Real-time PCR was performed in a final volume of 25 µL, using 5 µL of diluted DNA extracts (1/10 and 1/20), in an in-house TaqMan assay targeting the rep529 sequence and DNA-glycosylase anticontamination system, as previously described. 13 Amplification consisted in 2 min at 50°C, initial denaturation 10 min at 95°C, then 45 cycles of 95°C for 15 s and 60°C for 1 min. Each PCR was validated by negative and positive controls. The positive control was obtained by dilution of DNA extract from a calibrated sample sent by the NRC for toxoplasmosis (Montpellier, France). The sample was a lyophilised amniotic fluid artificially infected with T. gondii tachyzoites (RH strain). Data were collected with StepOnePlus Software V.2.2.2. PCR results were expressed as cycle threshold (C T ) of amplification.
statistics
Qualitative data were analysed using the χ 2 test. Quantitative data were analysed using Spearman r correlation test, MannWhitney test, or ANOVA and Tukey's multiple comparison tests. Calculations and graphs were realised with the GraphPad Prism V.5.03 software.
resulTs
Twenty-one seropositive mice infected with placentas from five different mothers were analysed. Three, one and one mothers acquired infection during the third, second and first trimester of pregnancy, respectively. Brain specimens were missing for four mice (entirely sent to the NRC) and heart specimen was missing for six mice (not collected). The five T. gondii clinical isolates were genotyped and were all type II.
As expected, all heart and brain samples were positive for T. gondii with high parasite loads (table 1) . Surprisingly, 90.5% of livers were infected (19/21) . No preferential localisation was identified: the percentage of infected lobes for a given anatomical site, ranged from 33.3% to 47.6% (non-significant differences). For each type of lobe, there were no significant differences between the mean weight of infected and uninfected lobes (data not shown). Parasite loads of hepatic lobes (mean C T =37.7±3.8) were far lower than that of heart and brain specimens (30.1±2.7 and 23.7±1.2, respectively), even reported to the weight of each organ. However, the parasite load was higher in the papillary process than in the right median, the left lateral and the caudal lobes (p ranging from <0.01 to <0.05), but no differences were observed between other lobes (figure 2).
The mean number of positive lobes per mice was 2.5±1.7. An inverse correlation between the number of positive lobes per mouse and the total liver weight (p<0.01) was observed (table 2), but no correlation was observed with the brain parasite load, nor with the delay between infection and sacrifice (ranging Original article from 9 to 33 weeks). The number of positive lobes per mouse was not linked the clinical isolate ( figure 3 ).
dIsCussIOn
The aim of this study was to describe the prevalence of Toxoplasma cyst carriage in the liver during chronic toxoplasmosis and to search for a preferential localisation of these cysts. We observed that the liver was a frequent target for Toxoplasma encystment, as DNA was detected in at least one hepatic lobe of 90% of mice (19/21) . This observation confirms that liver transplantation from a seropositive donor to a seronegative recipient is at high risk for the recipient. Consequently, anti-Toxoplasma chemoprophylaxis should be systematically recommended after liver transplantation in case of donor-recipient mismatch, like for heart transplantation. It is likely that the small number of Toxoplasma infection consecutive to donor-recipient mismatch is rather due to the frequent chemoprophylaxis against Pneumocystis jirovecii (sulfamethoxazole-trimethoprim), than to a low infectivity of the liver. Parasite loads appeared to be much lower than in brain and heart and was not correlated to the number of infected lobes. No lobe was predominantly infected in terms of frequency, but the papillary process had significantly higher parasite loads. These findings rule out the possibility to perform a systematic hepatic biopsy to detect Toxoplasma cysts before liver transplantation. The number of infected lobes in a liver could not be linked to the brain parasite load, which might reflect the initial parasitic inoculum. There was no difference according to the Toxoplasma isolate, suggesting that the intrahepatic distribution is not strain-dependent. We also observed that the liver weight was inversely correlated to the number of positive lobes. This could be related to PCR inhibition by high DNA amount, also possibly explaining the higher parasite loads detected in the papillary process, which is the smallest lobe.
The liver has probably a central role in the pathophysiology of toxoplasmosis. In 2014, Dadimoghaddam et al quantified parasite loads in various tissues of C57BL/6 mice after intraperitoneal inoculation of RH strain tachyzoites.
14 They observed high parasite loads in all tissues, particularly in the liver, which was the most rapidly infected organ. Twenty-four hours after infection, the hepatic parasite load was higher than in any other organ, including brain. Forty-eight and 72 hours later it decreased in the liver, while it was increasing in most other organs. In 2013, Unno et al highlighted that mononuclear cells infected by tachyzoites rapidly accumulated in the liver of C57BL/6 mice. 15 However, the frequency and the kinetics of parasite detection in tissues greatly depend on the model used: host species, route of infection, size of inoculum, time from infection to organ sampling and Toxoplasma strain type. In a murine model using Swiss mice, the brain and the liver were the least infected organs after infection with RH strain and ME49 strain, respectively. 16 Also, with the RH strain but using BALB/c mice, Wang et al observed higher parasite loads in the liver than in the brain. 17 Juránková et al quantified Toxoplasma in different tissues from artificially infected goats (ingestion of oocysts) 18 and showed that at 30 days postinfection (dpi), the liver was the least infected organ (50% of samples, with lowest parasite loads) but became one of the most infected ones at 90 dpi (100% of samples, fourth highest mean parasite load after lung, dorsal muscle and brain specimens). A study on pigs sacrificed at 76 dpi 19 showed 3/6 positive liver samples. Zöller et al showed, on 30 turkeys sacrificed 6-12 weeks after intravenous injection of tachyzoïtes, 20 that liver and breast muscle were the most infected organs, with Toxoplasma DNA detection in 43.3% and 26.7% of samples, respectively.
By contrast to the variability of these experimental models, here we provide a new insight into the natural prevalence of Toxoplasma cysts in the liver at distance from infection, using Original article variable inoculum sizes and variable parasite strains, thus more likely reflecting the probable distribution of parasites in natural conditions. All strains were confirmed as genotype II by the NRC. This genotype is the far most frequently isolated in Europe and Northern America. Contrasting with previous works, we extracted DNA from the entire organ. Although this allows to avoid the bias induced by a small biopsy, it is associated with a technical issue, that is, the presence of PCR inhibitors due to the high amount of DNA. Therefore, all DNA extracts were diluted to 1:10 and 1:20 for amplification. Low parasite loads combined with PCR inhibitors make the detection of T. gondii in large animals a tricky task, as already underlined, 21 yet we could amplify parasite DNA in most organs. Recently, two studies showed that Toxoplasma induces modifications of the transcription and translation profile of hepatocytes during acute infection, modifying multiple cellular pathways. [22] [23] [24] These data are consistent with a major role of the liver during acute toxoplasmosis, like in other parasitic infections, in particular visceral leishmaniasis, 25 26 where the liver displays a peculiar immune response leading to parasite control. The specific hepatic microenvironment might also contribute to limit Toxoplasma replication and could explain the low density of Toxoplasma remaining cysts. Hence, our results are challenging the possibility to localise cysts by a guided liver biopsy in humans to verify the frequency of cyst carriage.
In conclusion, together with the heart, the liver is also a frequent target organ for the chronic carriage of Toxoplasma cysts, thus liver recipients with Toxoplasma-mismatch transplantation should benefit from systematic chemoprophylaxis, which is not the rule in all countries. This preliminary study raises new questions: is this distribution of cysts similar in humans? Do Toxoplasma cysts have a long-term impact on the hepatic microenvironment and on the local response to infectious diseases or graft tolerance? Our observations open new perspectives of research to analyse the impact of long-term carriage of Toxoplasma cysts in the liver, even out of the transplant context.
Take home messages
► Liver is a frequent site of cyst carriage in chronically infected mice, although with low density. ► These findings justify systematic serological screening of liver donors and recipients before transplantation, and chemoprophylaxis of seronegative recipients who would receive a liver from a seropositive donor, a practice not uniformly applied in Europe.
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